Centers for Disease Control and Prevention, National Center for Respiratory Diseases, Division of Viral Diseases, Viral Vaccine Preventable Diseases Branch, Atlanta, GA, USA.
Center for Immunology and Infectious Diseases and Vaccines, National Institute for Public Health and Environment, Bilthoven, The Netherlands.
Methods Mol Biol. 2024;2808:225-246. doi: 10.1007/978-1-0716-3870-5_17.
There is increasing interest in evaluating antibody responses to multiple antigen targets in a single assay. Immunity to measles and rubella are often evaluated together because immunity is provided through combined vaccines and because routine immunization efforts and surveillance for measles and rubella pathogens are combined in many countries. The multiplex bead assay (MBA) also known as the multiplex immunoassay (MIA) described here combines the measurement of measles- and rubella-specific IgG antibodies in serum quantitatively according to international serum standards and has been successfully utilized in integrated serological surveillance.
人们越来越感兴趣的是在单次检测中评估针对多种抗原靶标的抗体反应。评估麻疹和风疹的抗体通常放在一起进行,这是因为这两种疾病都是通过联合疫苗来预防,而且在许多国家,麻疹和风疹病原体的常规免疫接种工作和监测也是结合在一起的。本文所描述的微珠多重检测法(MBA),也称为多重免疫分析法(MIA),根据国际血清标准对血清中麻疹和风疹特异性 IgG 抗体进行定量测量,并已成功应用于综合血清学监测。